Difference between revisions of "Thomas Crampton"
m (Text replacement - " COVID-19 vaccine " to " COVID-19 jab ") |
|||
| Line 18: | Line 18: | ||
'''Thomas Crampton''' In January 2021, he started leading corporate affairs, including [[marketing]], [[communications]] (PR) and government affairs (i.e. [[lobbyism]]), for [[GreenLight Biosciences]], a biotech company focused on cutting edge [[RNA research]], design and manufacturing. Before that he was a journalist for the [[New York Times]], an executive at [[Edelman]] and Global Principal for [[Ogilvy Consulting]]. | '''Thomas Crampton''' In January 2021, he started leading corporate affairs, including [[marketing]], [[communications]] (PR) and government affairs (i.e. [[lobbyism]]), for [[GreenLight Biosciences]], a biotech company focused on cutting edge [[RNA research]], design and manufacturing. Before that he was a journalist for the [[New York Times]], an executive at [[Edelman]] and Global Principal for [[Ogilvy Consulting]]. | ||
| − | GreenLight is applying [[RNA technology]] to human therapeutics including [[COVID-19 | + | GreenLight is applying [[RNA technology]] to human therapeutics including [[COVID-19 vaccine]] candidates, animal health, and plant health (crop protection) His role is to promote these projects with investors, partners, regulators, customers and the general public.<ref name=thomas>http://www.thomascrampton.com/about/</ref><ref>https://www.weforum.org/people/thomas-crampton</ref> |
==Career== | ==Career== | ||
For nearly two decades he was a [[foreign correspondent]] and columnist for [[The New York Times]] and [[International Herald Tribune]] based out of [[Asia]], [[Europe]] and the [[United States]], covering the[[SARS|2003 SARS outbreak]] in Asia, [[rare diseases in Africa]], the [[US/2004 Presidential Election|2004 U.S. presidential campaign]], [[economics]] and [[technology]].<ref name=thomas/> | For nearly two decades he was a [[foreign correspondent]] and columnist for [[The New York Times]] and [[International Herald Tribune]] based out of [[Asia]], [[Europe]] and the [[United States]], covering the[[SARS|2003 SARS outbreak]] in Asia, [[rare diseases in Africa]], the [[US/2004 Presidential Election|2004 U.S. presidential campaign]], [[economics]] and [[technology]].<ref name=thomas/> | ||
| − | + | Crampton then worked for 6 years at [[Ogilvy Consulting]], including as global managing director for Social@Ogilvy, leading more than 1,500 [[social media]] experts across over 60 territories. | |
After that he moved to [[Edelman]], where he was Chair of Edelman Digital practice, which employs more than 700 globally, reporting to [[Edelman]] president and CEO [[Richard Edelman]]<ref>https://www.adweek.com/agencies/edelman-digital-hires-ogilvy-vet-and-former-new-york-times-correspondent-as-global-lead/</ref>. Clients included [[Merck|MSD Merck]], [[Philips]], [[McKinsey]], [[Nestlé]] and [[Samsung]].<ref name=thomas/> | After that he moved to [[Edelman]], where he was Chair of Edelman Digital practice, which employs more than 700 globally, reporting to [[Edelman]] president and CEO [[Richard Edelman]]<ref>https://www.adweek.com/agencies/edelman-digital-hires-ogilvy-vet-and-former-new-york-times-correspondent-as-global-lead/</ref>. Clients included [[Merck|MSD Merck]], [[Philips]], [[McKinsey]], [[Nestlé]] and [[Samsung]].<ref name=thomas/> | ||
==The Commons Project== | ==The Commons Project== | ||
| − | + | Crampton joined GreenLight from [[Commons Project|The Commons Project Foundation]], where as the Chief Marketing and Communications Officer he led the launch of high-profile digital services and multi-[[stakeholder]] digital initiatives. <ref name=thomas/> | |
The Commons Project, a [[World Economic Forum]] project established with support from the [[Rockefeller Foundation]], is building digital services which it states is "for the common good". Its digital platform "allows people to collect and manage personal health data and sharing it with the health services, organizations and apps they trust"<ref>https://www.weforum.org/organizations/commons-project</ref>. This sharing is of course not voluntary. If people they ever want access to any service again, they will have to divulge this data. | The Commons Project, a [[World Economic Forum]] project established with support from the [[Rockefeller Foundation]], is building digital services which it states is "for the common good". Its digital platform "allows people to collect and manage personal health data and sharing it with the health services, organizations and apps they trust"<ref>https://www.weforum.org/organizations/commons-project</ref>. This sharing is of course not voluntary. If people they ever want access to any service again, they will have to divulge this data. | ||
Latest revision as of 16:01, 29 March 2022
 Thomas Crampton  (lobbyist, journalist) | |
|---|---|
 | |
| Nationality | US |
| Alma mater | University of Virginia, Trinity College (Dublin), Institut d’Etudes Politiques de Paris |
| Member of | WEF/Global Leaders for Tomorrow/2003, WEF/Young Global Leaders/2005 |
PR-executive who has worked on lots of WEF-connected projects, including the Commons Project. Per 2021 works as PR-manager for GreenLight Biosciences | |
Thomas Crampton In January 2021, he started leading corporate affairs, including marketing, communications (PR) and government affairs (i.e. lobbyism), for GreenLight Biosciences, a biotech company focused on cutting edge RNA research, design and manufacturing. Before that he was a journalist for the New York Times, an executive at Edelman and Global Principal for Ogilvy Consulting.
GreenLight is applying RNA technology to human therapeutics including COVID-19 vaccine candidates, animal health, and plant health (crop protection) His role is to promote these projects with investors, partners, regulators, customers and the general public.[1][2]
Career
For nearly two decades he was a foreign correspondent and columnist for The New York Times and International Herald Tribune based out of Asia, Europe and the United States, covering the2003 SARS outbreak in Asia, rare diseases in Africa, the 2004 U.S. presidential campaign, economics and technology.[1]
Crampton then worked for 6 years at Ogilvy Consulting, including as global managing director for Social@Ogilvy, leading more than 1,500 social media experts across over 60 territories.
After that he moved to Edelman, where he was Chair of Edelman Digital practice, which employs more than 700 globally, reporting to Edelman president and CEO Richard Edelman[3]. Clients included MSD Merck, Philips, McKinsey, Nestlé and Samsung.[1]
The Commons Project
Crampton joined GreenLight from The Commons Project Foundation, where as the Chief Marketing and Communications Officer he led the launch of high-profile digital services and multi-stakeholder digital initiatives. [1]
The Commons Project, a World Economic Forum project established with support from the Rockefeller Foundation, is building digital services which it states is "for the common good". Its digital platform "allows people to collect and manage personal health data and sharing it with the health services, organizations and apps they trust"[4]. This sharing is of course not voluntary. If people they ever want access to any service again, they will have to divulge this data.
A frequent public speaker, he has delivered keynote speeches at many leading events and universities, including the World Economic Forum in Davos, SXSW, Cannes Lions, Digital Life Design, Stanford University, Tokyo University and the Institut d’Etudes Politiques de Paris. [1]
Event Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| WEF/Annual Meeting/2004 | 21 January 2004 | 25 January 2004 | Switzerland | 2068 billionaires, CEOs and their politicians and "civil society" leaders met under the slogan Partnering for Prosperity and Security. "We have the people who matter," said World Economic Forum Co-Chief Executive Officer José María Figueres. |
